Everence Capital Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,090
Closed -$238K 963
2024
Q3
$238K Buy
6,090
+1,970
+48% +$78.5K 0.02% 672
2024
Q2
$211 Buy
+4,120
New +$199K 0.01% 669
2019
Q1
Sell
-3,270
Closed -$274K 642
2018
Q4
$274K Hold
3,270
0.06% 304
2018
Q3
$333K Sell
3,270
-600
-16% -$57.9K 0.07% 300
2018
Q2
$313K Hold
3,870
0.07% 301
2018
Q1
$285K Hold
3,870
0.06% 314
2017
Q4
$273K Hold
3,870
0.06% 325
2017
Q3
$242K Buy
+3,870
New +$229K 0.06% 324

Other funds holding NGVT

Everence Capital Management's NGVT Position: Q4 2024 in Review

Everence Capital Management sold out of Ingevity (NGVT) in Q4 2024, closing a stake of 6,090 shares — an estimated $238K sold.

Everence Capital Management first reported a position in NGVT in Q3 2017 and held it in 8 quarters. The position peaked at $333K in Q3 2018. 257 funds tracked by Wall St. Rank hold NGVT as of Q4 2024.

  • Everence Capital Management reported no remaining Ingevity position as of Q4 2024 after selling out during the quarter.
  • Everence Capital Management sold 6,090 Ingevity shares in Q4 2024, an estimated $238K.
  • Everence Capital Management first reported a position in Ingevity in Q3 2017 and held it in 8 quarters.
  • Everence Capital Management's Ingevity position peaked at $333K in Q3 2018.
  • 257 funds tracked by Wall St. Rank held Ingevity as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.